Introduction
The NMN Conference 2025, scheduled for May 9 and 10, 2025 at Palais Ferstel, Vienna, provides a unique platform for researchers, physicians and specialists to discuss innovations around Nicotinamide mononucleotide (NMN) and nuclear medicine. This congress brings together experts to discuss diagnostic and therapeutic advances, including important new insights on NMN, a molecule that shows promise in the fight against aging and diseases.
What is nicotinamide mononucleotide (NMN)?
Nicotinamide mononucleotide (NMN) is a precursor of NAD+, an essential coenzyme in cellular processes such as energy production, DNA repair and cell aging. At the NMN Conference 2025, researchers will present their recent findings on how NMN supplementation can contribute to improved health, longevity and treatment of conditions such as neurodegenerative diseases and cancer.
Location: Palais Ferstel, Vienna
Vienna’s historic Palais Ferstel provides a fitting venue for in-depth scientific discussions on NMN and nuclear medicine.
Key topics and innovations
The conference will focus on several important topics:
1. Radioligand therapy and precision medicine.
Experts discuss how NMN and radioligand therapy can complement each other in treatments for cancers and other conditions, with a special focus on neuro-oncology.
2. Molecular imaging and NMN
Advanced imaging techniques are presented, including studies examining the effects of NMN on cellular health via PET scans and other imaging techniques.
3. Theranostics with NMN
The integration of NMN into theranostic approaches is central, combining diagnosis and treatment to enable personalized therapies.
4. Bridging the blood-brain barrier.
New techniques are proposed to get NMN and other therapeutic agents into the brain more effectively, which is important in the treatment of brain tumors and neurodegenerative diseases.
5. NMN and neurodegenerative disorders.
The role of NMN supplementation in combating aging-related diseases such as Alzheimer’s and Parkinson’s is discussed in depth.
Program Overview
The program includes a range of sessions specifically focused on NMN:
Friday, May 9, 2025
- 09:45 – 10:00: Introduction by Nathalie L. Albert and Matthias Preusser
- 10:00 – 12:00: Radioligand therapy, NMN and precision oncology
- 13:00 – 14:00: Theranostics, NMN and application of radiopharmaceuticals
- 14:00 – 17:00: Abstract presentations highlighting recent NMN research.
- 19:00: Networking event ‘Heurigen’
Saturday, May 10, 2025
- 09:00 – 10:00: ‘Coffee with the Editors’.
- 10:00 – 12:00: Sessions on NMN, brain tumors and intra-arterial therapies
- 13:30 – 15:00: Interdisciplinary discussions on NMN, oncology and neurodegeneration
- 15:45 – 17:00: PET imaging of CNS tumors with a focus on NMN applications
Speakers and experts
Prominent experts such as Dr. Nathalie L. Albert and Prof. Matthias Preusser share their insights on NMN applications in neuro-oncology and medical innovations.
Registration and participation
Registration for the NMN Conference 2025 is available through the official conference page, with early registration opportunities until Feb. 28, 2025.
Conclusion
The NMN Conference 2025 provides a comprehensive platform to explore innovations around Nicotinamide mononucleotide and nuclear medicine. The event is essential for professionals interested in the potential of NMN within precision medicine and healthy aging.
More information and registration are available at: NMN Society
Sources:
Join the NMN Conference 2025 and discover the future of medical innovation and health!
